Loading...
XCNQ
AIML
Market cap8mUSD
Oct 07, Last price  
0.05CAD
1D
0.00%
1Q
12.50%
Jan 2017
-82.00%
IPO
-79.07%
Name

AI/ML Innovations Inc

Chart & performance

D1W1MN
XCNQ:AIML chart
P/E
—
P/S
137.61
EPS
—
Div yield, %
—
Shrs. gr., 5y
70.29%
Rev. gr., 5y
%
Revenues
83k
-50.36%
00000000000000065,409487,504600,137167,30783,058
Net income
-6m
L+38.39%
-160,000-276,000-258,000-201,000-1,661,000-3,546,000-674,000-454,000-638,000-462,00088,090-124,101-166,696-236,000-2,726,000-3,173,000-1,422,000-3,285,000-4,592,531-6,355,558
CFO
-5m
L+35.39%
-145,381-196,111-107,434-263,587-195,321-2,368,543-298,071-104,813-109,035-14,699-21,966-37,100-7,148-126,912-931,347-3,023,574-634,276-1,640,504-3,993,223-5,406,534

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Operating within the digital healthcare sector, AI/ML Innovations Inc. harnesses the power of artificial intelligence (AI) and machine learning (ML). The company's central offering is a patent-pending system for personal health monitoring and management, crafted to enable caregivers, patients, and medical professionals to readily access and utilize data. This functionality aims to enhance patient recovery outcomes and promote overall healthy living. Complementing this, AI/ML Innovations Inc. also develops digital health software and wearable technologies. The organization, incorporated in 2009, is based in Victoria, Canada, and rebranded from its former identity, AIML Resources Inc., in November 2020.

Key people

Terence Lee
Chief Financial Officer · since 2024
Erik Suokas
Chief Operating Officer · since 2026
Paul Duffy
Executive Chairman, President, Chief Executive Officer · since 2025
Esmat Naikyar
Chief Product Officer
Alan Rabinowitz
Chief Medical Officer, Director of Medical Partnerships · since 2025
Kendra Low
Company Secretary · since 2024
Jared Adelstein
Director · since 2025
Michael Diamond
Director · since 2025
Fabrice Pakin
Director · since 2023
Drew Dundas
Independent Director · since 2025
Nicholas Watters
Independent Director · since 2021
URL
https://www.aiml.health/
IPO date
Feb 13, 2020
Employees
Domiciled in
CA
Incorporated in
CA
Legal address
20TH FLOOR, 250 HOWE STREET
VANCOUVER, BC V6C 3R8
CA
Headquarters
203, 645 Fort Street
Victoria, BC V8W 1G2
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑042025‑042024‑042023‑042022‑042021‑042020‑042019‑042018‑042017‑04
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT